Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS(TM) (zopapogene imadenovec-drba), the first-and-only FDA-approved treatment for adults with RRP, in August 2025 -- ...
Ladies and gentlemen, welcome to DPC Dash Limited Full Year 2025 Earnings Conference Call. [Operator Instructions] Today's conference call will be recorded. At this time, I would like to turn the call ...
X Financial (NYSE: XYF), a leading Chinese fintech platform, today announced its unaudited financial results for the fourth ...
How the urban revitalization project Localize Gunsan breathed new life into a declining area by applying a pacer model that ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced financial results for the fourth ...
CBRE announced it arranged approximately $192 million in financing for a portfolio of deep technology and research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results